CHS Inc.

08/12/2024 | Press release | Archived content

CHS introduces new Trivar® EZ fertilizer

CHS Inc. today introduced the first of six new products designed to enhance growers' crop yields. New Trivar® EZ is an enhanced granular micronutrient fertilizer blend that features the Levesol® chelating agent, patented by CHS, that helps improve the availability of micronutrients to crops.

"CHS is dedicated to providing innovative agricultural solutions to farmers and retailers to support growers' profitability," said Brian Kuehl, senior director of research and development at CHS. "Trivar EZ helps growers make the most of their crop nutrient investment for solid economic returns."

Easily incorporated into dry commodity fertilizer products, Trivar EZ is a dry granular fertilizer blend with nutrients essential to early plant growth, including calcium, manganese, molybdenum, sulfur and zinc. Levesol, a chelate that unlocks soil nutrients, increases the availability of micronutrients and phosphate to boost the overall efficiency of nutrient uptake by the plant, resulting in healthier plants and better yield. Trivar EZ is a new dry, granular formulation of Trivar®, a liquid fertilizer. Learn more about Trivar EZ at CHSagronomy.com.

"Trivar EZ offers the industry's first granular ortho-ortho EDDHA chelated granular micronutrient blend, providing growers a new, more plant available, innovative fertility solution," Kuehl said.

Levesol is the patented chelation agent that helps the micronutrients in Trivar EZ be more available to the crop. This advanced chelate prevents phosphorus from bonding with soil micronutrients, freeing more nutrients for growing plants to access.

"It's the Levesol chelate, patented by CHS, that makes Trivar EZ a very efficient granular micronutrient blend," Kuehl said.

In addition to Trivar EZ, the CHS products coming available for the 2025 season include a biostimulant-talc blend and four fertilizer products focused on delivering micronutrients to crop plants. Those new products are:

  • Abivium: a graphite flow talc with micronutrients and a biostimulant
  • Soygreen® Pro: concentrated liquid iron product to alleviate iron deficiency chlorosis (IDC) in soybean fields
  • Soygreen® Granular 2.4: granular iron formulation for air seeder applications to treat IDC
  • Allocate ZN: concentrated zinc to add to dry commodity fertilizers
  • Allocate BCMZ: concentrated micronutrient formulation to add to dry commodity fertilizers

To learn more about the selection of products offered by CHS and the advantages of Trivar EZ, visit chsagronomy.com or contact your local CHS representative.

CHS Inc. (chsinc.com) creates connections to empower agriculture. As a leading global agribusiness and the largest farmer-owned cooperative in the United States, CHS serves customers in 65 countries and employs nearly 10,000 people worldwide. We provide critical crop inputs, market access and risk management services that help farmers feed the world. Our diversified agronomy, grains, foods and energy businesses recorded revenues of $45.6 billion in fiscal year 2023. We advance sustainability through our commitment to being stewards of the environment, building economic viability and strengthening community and employee well-being.

Always read and follow label directions. Results may vary based on soil conditions and application.

© 2024 CHS Inc. Abivium, Allocate ZN, Allocate BCMZ , Levesol®, Soygreen® Pro, Soygreen® Granular 2.4, and Trivar® EZ are trademarks of CHS Inc.

Share links

Related news and stories
Our people16 Aug 2024

Agronomist Sydney Swanson supports cooperative farmer-owners with farm planning, soil testing and more to help them have a successful year.

Agronomy9 Jul 2024

Jake Shelton, a crop nutrient expert with CHS, provides in-season crop nutrient strategies to help maximize yield potential.

Agronomy18 Jun 2024

Alissa Geske, research lead at the CHS Crop Science Research and Development Center, discusses how the new facility will speed up product development at a lower cost by conducting year-round research that complements field trials.